The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The 12th–14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain
Open accessAbstract
It has recently been shown that some growth factors (GFs) have strong interactions with nonproteoglycan extracellular matrix proteins. Relevant here, the 12th-14th type three repeats of fibronectin (FN III12-14) have been shown to bind insulin-like growth factor binding-protein-3, fibroblast growth factor (FGF)-2, and vascular endothelial growth factor (VEGF)-A with high affinity. Since FN III12-14 is known to bind GFs from different families, we hypothesized that this domain could be highly promiscuous in its GF-binding capacity. We used biochemical approaches and surface plasmon resonance to investigate such interactions with recombinant FN III12-14. We found that FN III12-14 binds most of the GFs from the platelet-derived growth factor (PDGF)/VEGF and FGF families and some GFs from the transforming growth factor-β and neurotrophin families, with K(D) values in the nanomolar range, without inhibiting GF activity. Overall, 25 new binding interactions were identified. In a clinically relevant fibrin matrix, a fibrin-binding variant of FN III12-14 was highly effective as a GF delivery system. For instance, in matrices functionalized with FN III12-14, PDGF-BB-induced sprouting of human smooth muscle cell spheroids was greatly enhanced. We show that FN III12-14 is a highly promiscuous ligand for GFs and also holds great potential in clinical healing applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
Discher, D. E., Mooney, D. J., & Zandstra, P. W. (2009) · Science · doi:10.1126/science.1171643 · Cited by 2,667
Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images
Meijering, E., Jacob, M., Sarria, J. ‐. F., Steiner, P., Hirling, H., & Unser, M. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20022 · Cited by 1,608
Interactions between extracellular matrix and growth factors in wound healing
Schultz, G. S., & Wysocki, A. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00466.x · Cited by 1,126
Fibronectin fibrillogenesis, a cell-mediated matrix assembly process
Mao, Y., & Schwarzbauer, J. E. (2005) · Matrix Biology · doi:10.1016/j.matbio.2005.06.008 · Cited by 816
Korff, T., & Augustin, H. G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.5.1341 · Cited by 559
Sakiyama-Elbert, S. E., & Hubbell, J. A. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00296-0 · Cited by 423
Self-citationHeparin Binds Endothelial Cell Growth Factor, the Principal Endothelial Cell Mitogen in Bovine Brain
Maciag, T., Mehlman, T., Friesel, R., & Schreiber, A. B. (1984) · Science · doi:10.1126/science.6382607 · Cited by 384
Covalently conjugated VEGF–fibrin matrices for endothelialization
Zisch, A. H., Schenk, U., Schense, J. C., Sakiyama-Elbert, S. E., & Hubbell, J. A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00266-8 · Cited by 350
Self-citationMartino, M. M., Mochizuki, M., Rothenfluh, D. A., Rempel, S. A., Hubbell, J. A., & Barker, T. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.047 · Cited by 324
Self-citationCross-Linking Exogenous Bifunctional Peptides into Fibrin Gels with Factor XIIIa
Schense, J. C., & Hubbell, J. A. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9800769 · Cited by 308
Self-citationWijelath, E. S., Rahman, S., Namekata, M., Murray, J., Nishimura, T., Mostafavi-Pour, Z., Patel, Y., Suda, Y., Humphries, M. J., & Sobel, M. (2006) · Circulation Research · doi:10.1161/01.res.0000246849.17887.66 · Cited by 293
Growth factor binding to the pericellular matrix and its importance in tissue engineering☆
MACRI, L., SILVERSTEIN, D., & CLARK, R. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.015 · Cited by 292 · cited 1×
“Thus, these interactions are essential for spatiotemporal coordination of different cellular activities to ensure correct morphogenesis and tissue repair (3).”
BackgroundBiomimetic materials in tissue engineering
Patterson, J., Martino, M. M., & Hubbell, J. A. (2010) · Materials Today · doi:10.1016/s1369-7021(10)70013-4 · Cited by 280
Self-citationControlled release of neurotrophin-3 from fibrin gels for spinal cord injury
Taylor, S. J., McDonald, J. W., & Sakiyama-Elbert, S. E. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.05.003 · Cited by 249
Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin
Sahni, A., Odrljin, T., & Francis, C. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7554 · Cited by 240
Wijelath, E. S., Murray, J., Rahman, S., Patel, Y., Ishida, A., Strand, K., Aziz, S., Cardona, C., Hammond, W. P., Savidge, G. F., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000026420.22406.79 · Cited by 240
Nugent, M. A., & Edelman, E. R. (1992) · Biochemistry · doi:10.1021/bi00152a026 · Cited by 236
McCaffrey, T. A., Falcone, D. J., & Du, B. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041520226 · Cited by 185
Rahman, S., Patel, Y., Murray, J., Patel, K. V., Sumathipala, R., Sobel, M., & Wijelath, E. S. (2005) · BMC Cell Biology · doi:10.1186/1471-2121-6-8 · Cited by 161
Droguett, R., Cabello‐Verrugio, C., Riquelme, C. A., & Brandan, E. (2006) · Matrix Biology · doi:10.1016/j.matbio.2006.04.004 · Cited by 155
Localization of the major heparin-binding site in fibronectin.
Barkalow, F. J., & Schwarzbauer, J. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89522-2 · Cited by 152
Hoshijima, M., Hattori, T., Inoue, M., Araki, D., Hanagata, H., Miyauchi, A., & Takigawa, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.061 · Cited by 145
Mitsi, M., Hong, Z., Costello, C. E., & Nugent, M. A. (2006) · Biochemistry · doi:10.1021/bi060974p · Cited by 96
Interaction of heparin with fibronectin and isolated fibronectin domains
Ingham, K. C., Brew, S. A., & Atha, D. H. (1990) · Biochemical Journal · doi:10.1042/bj2720605 · Cited by 93
Transforming growth factor‐β1 binds to immobilized fibronectin
Mooradian, D. L., Lucas, R., Weatherbee, J. A., & Furcht, L. T. (1989) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240410404 · Cited by 91
Kricker, J. A., Towne, C. L., Firth, S. M., Herington, A. C., & Upton, Z. (2003) · Endocrinology · doi:10.1210/en.2002-221086 · Cited by 88
A Catalytic Role of Heparin within the Extracellular Matrix
Mitsi, M., Forsten‐Williams, K., Gopalakrishnan, M., & Nugent, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806692200 · Cited by 81
Gui, Y., & Murphy, L. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7472 · Cited by 77
Smith, E. M., Mitsi, M., Nugent, M. A., & Symes, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902510106 · Cited by 66
Schoppet, M., Chavakis, T., Al‐Fakhri, N., Kanse, S. M., & Preissner, K. T. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780393 · Cited by 61
Xu, Q., Yan, B., Li, S., & Duan, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311586200 · Cited by 51
Antiangiogenic Properties of Fibstatin, an Extracellular FGF-2–Binding Polypeptide
Bossard, C., Berghe, L. V. D., Laurell, H., Castano, C., Cérutti, M., Prats, A., & Prats, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0287 · Cited by 51
Identification of a binding site on human FGF-2 for fibrinogen
Peng, H., Sahni, A., Fay, P. J., Bellum, S. C., Prudovsky, I. A., Maciag, T., & Francis, C. W. (2003) · Blood · doi:10.1182/blood-2003-08-2638 · Cited by 36
Insulin-Like Growth Factor-II Bound to Vitronectin Enhances MCF-7 Breast Cancer Cell Migration
Noble, A., Towne, C. L., Chopin, L. K., Leavesley, D. I., & Upton, Z. (2003) · Endocrinology · doi:10.1210/en.2002-221138 · Cited by 36
Capila, I., & Linhardt, R. J. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Translational Applications of Hydrogels
Correa, S., Grosskopf, A. K., Lopez Hernandez, H., Chan, D., Yu, A. C., Stapleton, L. M., & Appel, E. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01177 · Cited by 1,143
Materials as stem cell regulators
Murphy, W. L., McDevitt, T. C., & Engler, A. J. (2014) · Nature Materials · doi:10.1038/nmat3937 · Cited by 947
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair
Agarwal, R., & García, A. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.013 · Cited by 789
Metadata
- Authors
- Martino, M. M., & Hubbell, J. A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2010-12
- Volume
- 24
- Issue
- 12
- Pages
- 4711-4721
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2151810131
- Cited by
- 316
- References
- 36
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.